Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Amniotic Fluid for C-Section Scar Healing
NCT06531356Phase 4Completed
- Sponsor
- Kasr Al Ainy Hospital
- Start
- Feb 2024
- Primary completion
- May 2024
- Modality
- Biologic (Biologic)
- Countries
- 1
01
Overview
Phase 4, randomised trial of autologous amniotic fluid in surgical wound (2 arms), sponsored by Kasr Al Ainy Hospital. Primary endpoint: Quality of wound healing at 6 weeks. Started Feb 2024; status: completed.
02
Drugs
autologous amniotic fluid
03
Conditions
surgical wound
Beyond the preview
Go deeper on NCT06531356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06531356.